ACTRN12609000512224
Completed
Phase 1
Improved radiation delivery accuracy to the clinical treatment volume and concommitant reduction in incidental dose to organs-at-risk: assessment and optimisation of cone-beam computed tomography as a potential future standard of care for highly conformal radiation mono-therapy for prostate carcinoma
Perth Radiation Oncology0 sites75 target enrollmentJune 29, 2009
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Perth Radiation Oncology
- Enrollment
- 75
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Histologically confirmed prostate adenocarcinoma Localised prostate cancer of any T\-stage Gleason score and Prostate Specific Antigen (PSA)
- •Planned by Computed Tomography (CT) study for radical radiotherapy that is \- 7400 centigrays (cGy) in 37 fractions. Informed consents obtained for treatment and for clinical study
Exclusion Criteria
- •Prior radical prostatectomy.
- •Prior high dose pelvic radiation therapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A study aiming to improve the dosimetric accuracy of spot-scanning proton therapyMalignancyJPRN-UMIN000022765Hokkaido University Hospital150
Active, not recruiting
Not Applicable
Evaluation of Improved Onboard Patient ImagingHead and Neck CancerBreast CancerUpper Gastrointestinal CancerLung CancerPelvic CancerNCT06187103Varian, a Siemens Healthineers Company40
Completed
Phase 1
Radiation dosimetry, safety and pharmacokinetics of [11C]telmisartan as well as optimization of PET imaging in healthy volunteersHypertensionJPRN-UMIN000002446Foundation for Biomedical Research and Innovation9
Completed
Phase 1
Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in AdultsGlioblastomaNCT01043536Centre Georges Francois Leclerc10
Active, not recruiting
Phase 1
Can reduced dose radiotherapy delivered in standard fractionation improve the therapeutic index for stereotactic treatment of juxtapapillary choroidal melanoma?Juxtapapillary choroidal melanomaCancer - Malignant melanomaEye - Diseases / disorders of the eyeACTRN12614000531617Peter MacCallum Cancer Centre20